Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

[Amyloid imaging with 11C-PiB].

Ishii K.

Nihon Rinsho. 2011 Oct;69 Suppl 8:551-5. Japanese. No abstract available.

PMID:
22787849
2.

Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.

O'Keefe GJ, Saunder TH, Ng S, Ackerman U, Tochon-Danguy HJ, Chan JG, Gong S, Dyrks T, Lindemann S, Holl G, Dinkelborg L, Villemagne V, Rowe CC.

J Nucl Med. 2009 Feb;50(2):309-15. doi: 10.2967/jnumed.108.055756.

3.

Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment.

Tolboom N, van der Flier WM, Yaqub M, Koene T, Boellaard R, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN.

Neurology. 2009 Dec 15;73(24):2079-85. doi: 10.1212/WNL.0b013e3181c679cc.

PMID:
20018636
4.

[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.

Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC.

Neurology. 2006 Aug 8;67(3):446-52.

PMID:
16894106
5.

The proteomics of positron emission tomography.

Jagust W.

Ann Neurol. 2004 Mar;55(3):303-5. No abstract available.

PMID:
14991807
6.

Imaging beta-amyloid burden in aging and dementia.

Linazasoro G.

Neurology. 2008 Apr 29;70(18):1649; author reply 1650. doi: 10.1212/01.wnl.0000318046.06992.24. No abstract available.

PMID:
18443321
7.

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX, Loetscher H, Santarelli L.

Arch Neurol. 2012 Feb;69(2):198-207. doi: 10.1001/archneurol.2011.1538.

PMID:
21987394
8.

Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B.

Johnson KA.

Curr Neurol Neurosci Rep. 2006 Nov;6(6):496-503. Review.

PMID:
17074285
9.

[Amyloid PET imaging with [18F]AV-45].

Tateno A, Okubo Y.

Nihon Rinsho. 2011 Oct;69 Suppl 8:561-4. Japanese. No abstract available.

PMID:
22787851
10.

Traumatic brain injury: PET imaging detects amyloid deposits after TBI.

Malkki H.

Nat Rev Neurol. 2014 Jan;10(1):3. doi: 10.1038/nrneurol.2013.250. No abstract available.

PMID:
24296658
11.

The exception makes the rule: not all Aβ plaques are created equal.

Ringman JM, Teplow DB, Villemagne VL.

Neurology. 2012 Jul 17;79(3):206-7. doi: 10.1212/WNL.0b013e31825fe11f. No abstract available.

PMID:
22700807
12.

The specificity of amyloid imaging in the diagnosis of neurodegenerative diseases.

Frisoni GB, Giannakopoulos P.

Neurobiol Aging. 2012 Jun;33(6):1021-2. doi: 10.1016/j.neurobiolaging.2010.09.007. No abstract available.

PMID:
20965612
13.

Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.

Morris JC, Selkoe DJ.

Neurobiol Aging. 2011 Dec;32 Suppl 1:S1-3. doi: 10.1016/j.neurobiolaging.2011.09.005. No abstract available.

PMID:
22078168
14.

First FDA-approved beta-amyloid diagnostic hits the market.

Garber K.

Nat Biotechnol. 2012 Jul 10;30(7):575. doi: 10.1038/nbt0712-575. No abstract available.

PMID:
22781668
15.

Different β-amyloid binding patterns in Alzheimer and Parkinson diseases: it's the network!

Eidelberg D, Martin W.

Neurology. 2013 Aug 6;81(6):516-7. doi: 10.1212/WNL.0b013e31829e703e. No abstract available.

PMID:
23825171
16.

[Alcadein].

Suzuki T, Hata S.

Nihon Rinsho. 2011 Oct;69 Suppl 8:110-4. Japanese. No abstract available.

PMID:
22787764
17.

Beta A4-amyloid in the brains of non-demented Nigerian Africans.

Osuntokun BO, Ogunniyi A, Akang EE, Aghadiuno PU, Ilori A, Bamgboye EA, Beyreuther K, Masters C.

Lancet. 1994 Jan 1;343(8888):56. No abstract available.

PMID:
7905067

Supplemental Content

Support Center